IEFM
PACB icon

IQ EQ Fund Management’s Pacific Biosciences PACB Stock Holding History

IQ EQ Fund Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Sell
1,788,393
-106,538
-6% -$191K 0.18% 130
2025
Q4 		$3.54M Buy
1,894,931
+606,239
+47% +$1.16M 0.24% 106
2025
Q3 		$1.65M Buy
1,288,692
+499,421
+63% +$676K 0.11% 163
2025
Q2 		$979K Buy
789,271
+471,101
+148% +$544K 0.09% 208
2025
Q1 		$375K Buy
318,170
+154,688
+95% +$237K 0.04% 253
2024
Q4 		$299K Buy
163,482
+96,118
+143% +$188K 0.04% 256
2024
Q3 		$115K Buy
67,364
+23,619
+54% +$38.8K 0.01% 313
2024
Q2 		$59.9K Buy
+43,745
New +$88.3K 0.01% 307

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return